NDA or New Drug Application
Health Care Term
The NDA process involves multiple steps, including preclinical studies, clinical trials, and a rigorous review by the FDA. The FDA typically takes several months to review an NDA and may request additional information or clarification from the drug manufacturer before making a final decision.
Once approved, the drug can be legally marketed in the United States for its intended use and is given a unique identification number. The drug manufacturer is also responsible for ongoing monitoring of the drug*s safety and effectiveness and must report any adverse events to the FDA.
The NDA process is critical in the healthcare industry, as it is the primary mechanism through which new drugs are evaluated for safety and efficacy. It ensures that only drugs that have undergone rigorous testing and meet the FDA*s standards for safety and effectiveness are available to patients. It also plays an important role in controlling healthcare costs by reducing the likelihood of harmful or ineffective drugs being prescribed.
More Glossary Terms Beginning with N
-
Nanotechnology
Manufacturing Term Letter: N
-
National Association of Insurance Commissioners NAIC
Insurance Term Letter: N
-
National income NI
Economy Term Letter: N
-
Natural Gas Equivalents
Energy Term Letter: N
-
Natural Gas Liquids
Energy Term Letter: N
-
Natural Gas Liquids NGL
Energy Term Letter: N
-
NDA or New Drug Application
Health Care Term Letter: N
-
Net Asset Value NAV
Financial Term Letter: N
-
Net Card Fees
Financial Term Letter: N
-
Net domestic product NDP
Economy Term Letter: N
-
Net exports of goods and services
Economy Term Letter: N
-
Net government saving
Economy Term Letter: N
